HCPCS G9096

Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as predominant cell type; extent of disease initially established as t1-t3, n0-n1 or nx (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)

Current code0 hospitals with prices

Description from CMS's HCPCS Level II code file.

What Washington hospitals publish for this code

No Washington hospital publishes a dollar price for this code yet.

Medicare (traditional) reference

CMS publishes no national amount for this code.